• Citer

Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.

par Felip, Enriqueta;Smit, Egbert F;Molina-Vila, Miguel A;Dafni, Urania;Massuti, Bartomeu;Berghmans, Thierry ;de Marinis, Filippo;Passiglia, Francesco;Dingemans, Anne-Marie C;Cobo, Manuel;Viteri, Santiago;Britschgi, Christian;Cuffe, Sinead;Provencio, Mariano;Merkelbach-Bruse, Sabine;Andriakopoulou, Charitini;Kammler, Roswitha;Ruepp, Barbara;Roschitzki-Voser, Heidi;Peters, Solange;Wolf, Jürgen;Stahel, Rolf Arno R.;ETOP 12-17 ALERT-lung Collaborators,
Référence Lung cancer, 172, page (94-99)
Publication Publié, 2022-08

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.
Auteur:	Felip, Enriqueta; Smit, Egbert F; Molina-Vila, Miguel A; Dafni, Urania; Massuti, Bartomeu; Berghmans, Thierry; de Marinis, Filippo; Passiglia, Francesco; Dingemans, Anne-Marie C; Cobo, Manuel; Viteri, Santiago; Britschgi, Christian; Cuffe, Sinead; Provencio, Mariano; Merkelbach-Bruse, Sabine; Andriakopoulou, Charitini; Kammler, Roswitha; Ruepp, Barbara; Roschitzki-Voser, Heidi; Peters, Solange; Wolf, Jürgen; Stahel, Rolf Arno R.; ETOP 12-17 ALERT-lung Collaborators,
Informations sur la publication:	Lung cancer, 172, page (94-99)
Statut de publication:	Publié, 2022-08
Sujet CREF:	Sciences bio-médicales et agricoles
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0169-5002
	info:doi/10.1016/j.lungcan.2022.08.008
	info:pii/S0169-5002(22)00595-5
	info:scp/85136469435
	info:pmid/36030612